Meanwhile, Novo Nordisk has direct exposure to one of the decades strongest secular growth themes
Semaglutide represents an important advance in the pediatric obesity management, with clear short-term reductions in BMI and improvement in metabolic parameters
Supports the conversion of fat into usable energy
Urinary Tract Infection or Kidney Concerns Painful urination (dysuria), urgency with small urine volumes, cloudy or foul-smelling urine, pelvic discomfort, or fever may indicate a urinary tract infection (UTI)
[DOI] [PMC free article] [PubMed] [Google Scholar] 218.Dycus D.L., Au A.Y., Grzanna M.W., Wardlaw J.L., Frondoza C.G
Orforglipron (Lilly) : Lilly says it submitted for obesity/overweight in 2025 and plans a type 2 diabetes submission in 2026